CRA InternationalCRAI
Recorded

CRA International 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration40 minParticipants7

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good day, everyone, and welcome to Charles River Associates' third quarter 2026 conference call. Please note that today's call is being recorded. The company's earnings release and prepared CFO remarks are posted on the investor relations section of CRA's website at crai.com. With us today are CRA's President and Chief Executive Officer, Paul Maleh, Chief Financial Officer, Eric Nierenberg, and Chief Corporate Development Officer, Chad Holmes. At this time, I'd like to turn the call over to Dr. Nierenberg for opening remarks.

Eric NierenbergCFO

Eric, please go ahead. Thank you, Rob, and good morning, everyone.

Eric NierenbergCFO

Please note that the statements made during this conference call, including guidance on future revenue and non-GAAP EBITDA margin, and any other statements concerning the future business, operating results, or financial condition of CRA, including those statements using the terms expect, outlook, or similar terms, are forward-looking statements as defined in Section 21E of the Exchange Act. Information contained in these forward-looking statements is based on management's current expectations and is inherently uncertain. Actual performance and results may differ materially from those expressed or implied in these statements due to many important factors, including the level of demand for our services as a result of changes in general and industry-specific economic conditions.

Eric NierenbergCFO

Additional information regarding these factors is included in today's release and in CRA's periodic reports, including our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC. CRA undertakes no obligation to update these forward-looking statements after the date of this call to reflect new information or developments. Additionally, we will refer to some non-GAAP financial measures and certain measures presented on a constant currency basis on this call. Everyone is encouraged to refer to today's release and related CFO remarks for reconciliations of these non-GAAP financial measures to their GAAP comparable measures and descriptions of the calculation of EBITDA and measures presented on a constant currency basis. I will now turn it over to Paul for his report.

Paul MalehPresident and CEO

Paul? Thanks, Eric, and good morning, everyone.

Paul MalehPresident and CEO

Thank you for joining us today. CRA's strong performance continued in the third quarter as we set a new quarterly record for financial performance. Revenue grew by 15.6% year over year to $214.9 million, representing the highest quarterly revenue in CRA's history.

Speaker

This follows record revenue in the- I found this on the web for revenue grew by 15.6%.

Paul MalehPresident and CEO

Siri loves the results too. I apologize for that. This follows record revenue in the first and second quarters, which means fiscal 2026 has delivered the three highest quarters of revenue in our history. Broad-based contributions once again characterize CRA's financial performance, reflecting both the quality and the depth of the portfolio. Seven practices grew year-over-year, representing approximately 95% of the company's total revenue for the third quarter. The Forensic Services, Life Sciences, and Risk, Investigations & Analytics practices each posted double-digit revenue growth year-over-year. Four practices, Antitrust & Competition Economics, Energy, Forensic Services, and Life Sciences, each established new records for the strongest first nine months of the year. During this period of strong growth, we have continued to manage the business effectively.

Paul MalehPresident and CEO

The record top-line performance translated into the highest Q3 profits in the company's history, as measured by net income, earnings per diluted share, and EBITDA. We are particularly pleased with these levels of profitability given the step-up in forgivable loan amortization expense during fiscal 2026, which we have referenced previously. During the third quarter, we welcomed approximately 100 new consultants as headcount increased 6.2% compared to the third quarter of 2025. Consultant utilization rose to 78% versus 77% a year ago. Summer is a period of significant seasonal transition with large inflows and outflows of consultants, particularly within our junior ranks, so we are especially pleased with this high level of utilization. The increase in overall consultant headcount and utilization were supported by the continued replenishing of our sales pipeline.

Paul MalehPresident and CEO

Average weekly project lead flow and new project originations remained strong, with each metric increasing more than 20% year-over-year. This growth continues the momentum we generated in the first half of fiscal 2026. Revenue in the third quarter from CRA's legal and regulatory services increased by 15.7%. This growth outpaced trends in the broader legal market as total case filings and total court judgments increased year-over-year by 8% and 4%, respectively, excluding the effects of a one-time surge in employment-related case filings during the quarter. Turning to the M&A market, worldwide M&A activity totaled $3.9 trillion during the first nine months of 2026, an increase of 28% compared to year-ago levels, making it the strongest first three quarters to start a year since 2021.

Paul MalehPresident and CEO

However, the third quarter of 2026 totaled $993 billion, a decrease of 41% compared to the second quarter of this year, the slowest quarter for M&A by value since the second quarter of 2025. Against this backdrop, CRA's Antitrust & Competition Economics practice posted its seventh straight record quarter, capitalizing on ongoing merger-related activity and sustained demand for antitrust services. For example, CRA was retained by Paramount Skydance Corporation to advise on its acquisition of Warner Bros. Discovery. The CRA team provided economic assistance to Paramount during the Department of Justice investigation and through litigation brought by 12 states and the Writers Guild of America. These lawsuits were settled in late September, and the transaction closed on October 6th, 2026. In another project, CRA supported the Canadian Competition Bureau in challenging Nortera Foods proposed acquisition of B&G Foods Canada.

Paul MalehPresident and CEO

CRA's expert found that the transaction likely would harm competition across multiple alternative market definitions. Following the Competition Bureau's application to block the transaction, the merging parties abandoned the transaction. CRA's Antitrust & Competition Economics practice remained active in high-stakes legal disputes during the third quarter, working on multiple U.S. antitrust agency investigations into ordinary course of business practices. Additionally, CRA supported Compass in the federal antitrust lawsuit brought by Zillow against Compass and Midwest Real Estate Data over the availability of private real estate listings. Zillow alleged coordination and coercion and sought a preliminary injunction. Citing the CRA expert in his ruling, the judge denied Zillow's motion for a preliminary injunction. During the third quarter, CRA's Forensic Services practice once again set a new high for quarterly revenue while responding to numerous types of crisis management events experienced by our client.

Paul MalehPresident and CEO

For example, the team recently supported a global Silicon Valley-based technology company in responding to a significant regulatory matter involving substantial volumes of electronically stored information. Working under compressed deadlines, our team rapidly processed and securely hosted the data and managed complex time-sensitive productions. Elsewhere, a global software developer asked CRA to use AI to find unknown vulnerabilities in its products. Taking advantage of multiple models and industry experience, we rapidly identified, triaged, and tested security fixes for their products before a vulnerability could be exploited. During the third quarter, the Risk, Investigations & Analytics team worked on several large investigations and damages matters across multiple jurisdictions. In one, the RIA team was retained by a client in the financial sector to provide expert assistance and testimony regarding the reasonableness of processes and controls to prevent the misappropriation of assets.

Paul MalehPresident and CEO

In another engagement, an insurance industry client retained a CRA expert to quantify economic damages arising from a breach of contract and employee raiding matter. Turning to our management consulting services, this line of business expanded 9.8% year over year as both the Energy and Life Sciences practices contributed to overall revenue growth. During the third quarter, CRA's Energy practice continued to advise utilities, data center developers, and investors on the power supply and infrastructure requirements associated with growing data center demand. Our work included electricity demand forecasting, data center portfolio assessment, and due diligence on dedicated generation investments, as well as advice on utility service options, pricing, and commercial arrangements for large customers. We also supported major electricity market operators on market design and resource adequacy. In our Life Sciences practice, we continue to focus on the new commercial opportunities that scientific advances create.

Paul MalehPresident and CEO

Our strategy consulting teams led qualitative and quantitative market research in China, France, Germany, the U.K., and the U.S. on a new asset to treat liver disease. The market research will be used by our strategy consultants to inform perspectives on product positioning within the rapidly evolving treatment landscape. Regarding litigation support, one of our economists was retained as an expert witness in an Antitrust & Competition Economics matter involving allegations of vertical foreclosure in the generic pharmaceutical industry, and the CRA team is providing economic analysis on a market definition, vertical foreclosure, and damages. As always, I'm grateful to all of my colleagues for their hard work and their commitment in helping our clients address their most important challenges. Fiscal 2026 has delivered the strongest nine months for revenue, non-GAAP EBITDA in the company's history.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day